Robinson Chandler - Insider Non-Derivative Transactions at Monopar Therapeutics (MNPR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 30, 2024, Robinson Chandler's relationship to Monopar Therapeutics (MNPR) is Director,Officer (Chief Executive Officer), and currently has 274,606.8 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other MNPR insiders.
Data Source: SEC.
Robinson Chandler - Insider Non-Derivative Transactions of MNPR Common Stock
Robinson Chandler - Insider Non-Derivative Transactions at MNPR
Items per page:
0 of 0
Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
---|---|---|---|---|
Jul 1, 2024 | F -- (Common Stock) | 8684 | 0.73 | 265922.8 |
Jul 1, 2024 | M -- (Common Stock) | 24476 | 0 | 274606.8 |
May 29, 2024 | X -- (Common Stock) | 84000 | 0 | 250130.8 |
Apr 1, 2024 | F -- (Common Stock) | 7172 | 0.68 | 166130.8 |
Apr 1, 2024 | M -- (Common Stock) | 24474 | 0 | 173302.8 |
Jan 2, 2024 | F -- (Common Stock) | 2327 | 0.34 | 148828.8 |
Jan 2, 2024 | M -- (Common Stock) | 6724 | 0 | 151155.8 |
Jan 1, 2024 | F -- (Common Stock) | 8469 | 0.34 | 144431.8 |
Jan 1, 2024 | M -- (Common Stock) | 24474 | 0 | 152900.8 |
Oct 1, 2023 | F -- (Common Stock) | 7172 | 0.62 | 128426.8 |
Oct 1, 2023 | M -- (Common Stock) | 24474 | 0 | 135598.8 |
Jul 1, 2023 | F -- (Common Stock) | 10269 | 0.86 | 111124.8 |
Jul 1, 2023 | M -- (Common Stock) | 35039 | 0 | 121393.8 |
Apr 1, 2023 | F -- (Common Stock) | 4286 | 1.39 | 86354.8 |
Apr 1, 2023 | M -- (Common Stock) | 13911 | 0 | 90640.8 |
Jan 2, 2023 | F -- (Common Stock) | 2327 | 2.37 | 76729.8 |
Jan 2, 2023 | M -- (Common Stock) | 6723 | 0 | 79056.8 |
Jan 1, 2023 | F -- (Common Stock) | 4814 | 2.37 | 72333.8 |
Jan 1, 2023 | M -- (Common Stock) | 13912 | 0 | 77147.8 |